Technical Analysis for OPTN - OptiNose, Inc.

Grade Last Price % Change Price Change
grade A 20.48 1.14% 0.23
OPTN closed up 1.14 percent on Wednesday, April 25, 2018, on 58 percent of normal volume.
0 Watchers
Intraday Alerts Watchlist Portfolio

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong N/A Up Up
See historical OPTN trend table...

Date Alert Name Type % Chg
Apr 25 Inside Day Range Contraction 0.00%
Apr 25 Up 3 Days in a Row Strength 0.00%
Apr 25 Up 4 Days in a Row Strength 0.00%
Apr 25 Up 5 Days in a Row Strength 0.00%
Apr 25 Upper Bollinger Band Touch Strength 0.00%
Apr 24 Up 3 Days in a Row Strength 1.14%
Apr 24 Up 4 Days in a Row Strength 1.14%
Apr 24 Upper Bollinger Band Touch Strength 1.14%
Apr 23 Narrow Range Bar Range Contraction 1.59%
Apr 23 NR7 Range Contraction 1.59%

Older signals for OPTN ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Get Started for Free!
Configure default chart indicators
Basic chart:
Profile
OptiNose, Inc. is a pharmaceutical company. The Company is focused on the development and commercialization of products for patients treated by ear, nose and throat, or ENT, and allergy specialists. The Company’s products candidates include XHANCE (Nasal Polyps), XHANCE (Chornic Sinusitis) OPN-300, OPN-021, and other. The Company’s lead product, XHANCE (fluticasone propionate) nasal spray, utilizes breath powered exhalation delivery system (EDS), to deliver a topically acting and potent anti-inflammatory corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps. XHANCE has a differentiated clinical profile with the potential to become part of the standard of care for this disease because it is able to deliver medication to the primary site of inflammation
Is OPTN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Apr 3 Investors Should Opt Out Of OptiNose Before IPO Lock-Up Expires
Mar 18 OptiNose's (OPTN) CEO Peter Miller on Q4 2017 Results - Earnings Call Transcript
Mar 16 Award time: Life Sciences Pennsylvania hands out annual industry awards
Mar 15 Optinose Named Emerging Company of the Year by Life Sciences Pennsylvania
Mar 14 OptiNose, Inc. 2017 Q4 - Results - Earnings Call Slides
Mar 13 OptiNose reports 4Q loss
Mar 13 OptiNose misses by $0.14
Mar 13 Optinose Reports Fourth Quarter and Full Year 2017 Financial Results and Recent Operational Highlights
Mar 6 Optinose to Report Fourth Quarter and Full Year 2017 Financial Results and Corporate Updates on March 13, 2018
Feb 27 Optinose to Highlight Data at the 2018 AAAAI/WAO Joint Congress
See more OPTN news...
Indicators
Indicator Value
52 Week High 25.24
52 Week Low 15.01
Average Volume 80,640
200-Day Moving Average 0.0
50-Day Moving Average 18.7304
20-Day Moving Average 19.743
10-Day Moving Average 20.006
Average True Range 1.3425
ADX 27.29
+DI 24.04
-DI 13.56
Chandelier Exit (Long, 3 ATRs ) 21.2125
Chandelier Exit (Short, 3 ATRs ) 21.8975
Upper Bollinger Band 20.6893
Lower Bollinger Band 18.7967
Percent B (%b) 0.89
BandWidth 9.586182
MACD Line 0.3614
MACD Signal Line 0.3351
MACD Histogram 0.0263
Fundamentals Value
Market Cap 773.35 Million
Num Shares 37.8 Million
EPS -19.61
Price-to-Earnings (P/E) Ratio -1.04
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 21.79
Resistance 3 (R3) 21.80 21.37 21.57
Resistance 2 (R2) 21.37 21.04 21.37 21.49
Resistance 1 (R1) 20.93 20.84 21.15 20.92 21.42
Pivot Point 20.50 20.50 20.62 20.50 20.50
Support 1 (S1) 20.06 20.17 20.28 20.05 19.54
Support 2 (S2) 19.63 19.97 19.63 19.47
Support 3 (S3) 19.19 19.63 19.39
Support 4 (S4) 19.18